CD274 and Autoimmunity: Importantly, β-cell autoantibody positivity and combination regimens that co-blockade PD-1/PD-L1 and CTLA-4 are consistently associated with a higher likelihood of DKA, indicating that host autoimmunity and treatment intensity jointly shape disease severity (14, 15).